| Teresa K Krappes, MS, CCC-SLP | |
|
100 Cobble Ct, Windsor, CO 80550-6136 | |
| (970) 674-1781 | |
| Not Available |
| Full Name | Teresa K Krappes |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 100 Cobble Ct, Windsor, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194947135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa K Krappes, MS, CCC-SLP 100 Cobble Ct, Windsor, CO 80550-6136 Ph: (970) 674-1781 | Teresa K Krappes, MS, CCC-SLP 100 Cobble Ct, Windsor, CO 80550-6136 Ph: (970) 674-1781 |
News Archive
A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.
Issues ranging from plans to cap or cut Medicaid spending to voting positions on the Medicare prescription drug program are among the policies being tossed about as candidates jockey for Tea Party votes and conservative credentials.
ACT Biotech, Inc., a biopharmaceutical company focused on the development of highly targeted, oral therapeutics for the treatment of cancer, announced today that it has filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase 3 trial of telatinib in combination with chemotherapy for the first-line treatment of patients with advanced stomach cancer.
BNY Mellon, the global leader in asset management and securities servicing, has been appointed by Takeda Pharmaceutical Company Limited (Takeda) as the depositary bank for its sponsored American depositary receipt (ADR) program. Each Takeda ADR represents one-half of a common share and trades on the over-the-counter (OTC) market under the symbol TKPYY. Takeda's common shares trade on the Tokyo Stock Exchange as well as four other exchanges in Japan under the code "4502." Previously, Takeda traded as an unsponsored ADR program serviced by multiple depositaries.
› Verified 7 days ago
Heidi Jill Jahnke, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4650 Royal Vista Cir, Windsor, CO 80528 Phone: 970-305-5070 | |
Mrs. Lisa Nicole Ayers, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 561 E Garden Dr Unit B, Windsor, CO 80550 Phone: 970-833-5686 Fax: 970-833-5687 | |
Brooke M Fischer, MHS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 Barnwood Ct, Windsor, CO 80550 Phone: 573-275-4618 | |
Bloom In Connection Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 991 Columbine Dr, Windsor, CO 80550 Phone: 970-372-8204 | |
Mrs. Bailey Kaye Yerby, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 561 E Garden Dr Unit B, Windsor, CO 80550 Phone: 970-833-5686 Fax: 970-833-5687 | |
Kayla Dawn Reed-baum, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 710 3rd St, Windsor, CO 80550 Phone: 970-686-7474 | |
Ms. Bethany A Biehl, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13 Main St, Windsor, CO 80550 Phone: 970-308-7414 |